Cargando…

Brief Report: Cessation of Long-Term Cotrimoxazole Prophylaxis in HIV-Infected Children Does Not Alter the Carriage of Antimicrobial Resistance Genes

BACKGROUND: Cotrimoxazole (CTX) is a broad-spectrum antimicrobial, combining trimethoprim and sulfamethoxazole. CTX prophylaxis reduces mortality and morbidity among people living with HIV in regions with high prevalence of bacterial infections and malaria. The Antiretroviral research for Watoto tri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Francis, Freddy, Gough, Ethan K., Edens, Thaddeus J., Berejena, Chipo, Bwakura-Dangarembizi, Mutsawashe, Shonhai, Annie, Nathoo, Kusum J., Glass, Magdalena, Gibb, Diana M., Prendergast, Andrew J., Manges, Amee R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JAIDS Journal of Acquired Immune Deficiency Syndromes 2020
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654951/ https://www.ncbi.nlm.nih.gov/pubmed/32852361 http://dx.doi.org/10.1097/QAI.0000000000002489

Ejemplares similares

Pubertal development in HIV-infected African children on first-line antiretroviral therapy
por: Szubert, Alexander J., et al.
Publicado: (2015)

Reduced bacterial skin infections in HIV-infected African children randomized to long-term cotrimoxazole prophylaxis
por: Prendergast, Andrew J., et al.
Publicado: (2016)

Prevalence of Lipodystrophy and Metabolic Abnormalities in HIV-infected African Children after 3 Years on First-line Antiretroviral Therapy
por: Bwakura-Dangarembizi, Mutsawashe, et al.
Publicado: (2015)

Baseline Inflammatory Biomarkers Identify Subgroups of HIV-Infected African Children With Differing Responses to Antiretroviral Therapy
por: Prendergast, Andrew J., et al.
Publicado: (2016)

Ethical and legal constraints to children’s participation in research in Zimbabwe: experiences from the multicenter pediatric HIV ARROW trial
por: Bwakura-Dangarembizi, Mutsa, et al.
Publicado: (2012)

Antimicrobial Resistance Gene Acquisition and Depletion Following Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
por: Leung, Victor, et al.
Publicado: (2018)

Opportunities for improving the efficiency of paediatric HIV treatment programmes
por: Revill, Paul A., et al.
Publicado: (2015)

Assessing the Intestinal Microbiota in the SHINE Trial
por: Gough, Ethan K., et al.
Publicado: (2015)

Trends of rubella incidence during a 5-year period of case based surveillance in Zimbabwe
por: Chimhuya, Simbarashe, et al.
Publicado: (2015)

Bloom and bust: intestinal microbiota dynamics in response to hospital exposures and Clostridium difficile colonization or infection
por: Vincent, Caroline, et al.
Publicado: (2016)

Risk factors for postdischarge mortality following hospitalization for severe acute malnutrition in Zimbabwe and Zambia
por: Bwakura-Dangarembizi, Mutsa, et al.
Publicado: (2021)

Linear growth trajectories in Zimbabwean infants(1)(2)
por: Gough, Ethan K, et al.
Publicado: (2016)

Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy
por: Crook, Angela M., et al.
Publicado: (2016)

Late Presentation With HIV in Africa: Phenotypes, Risk, and Risk Stratification in the REALITY Trial
por: Siika, Abraham, et al.
Publicado: (2018)

Carriage of antibiotic-resistant Enterobacteriaceae in hospitalised children in tertiary hospitals in Harare, Zimbabwe
por: Magwenzi, Marcelyn T., et al.
Publicado: (2017)

Reductions in intestinal Clostridiales precede the development of nosocomial Clostridium difficile infection
por: Vincent, Caroline, et al.
Publicado: (2013)

Erratum to: Linear growth faltering in infants is associated with Acidaminococcus sp. and community-level changes in the gut microbiota
por: Gough, Ethan K., et al.
Publicado: (2016)

Linear growth faltering in infants is associated with Acidaminococcus sp. and community-level changes in the gut microbiota
por: Gough, Ethan K., et al.
Publicado: (2015)

Fat and lean mass predict time to hospital readmission or mortality in children treated for complicated severe acute malnutrition in Zimbabwe and Zambia
por: Bwakura-Dangarembizi, Mutsa, et al.
Publicado: (2023)

The gut microbiome and early-life growth in a population with high prevalence of stunting
por: Robertson, Ruairi C., et al.
Publicado: (2023)

Marginal structural models for repeated measures where intercept and slope are correlated: An application exploring the benefit of nutritional supplements on weight gain in HIV-infected children initiating antiretroviral therapy
por: Farmer, Ruth E., et al.
Publicado: (2020)

Maternal fecal microbiome predicts gestational age, birth weight and neonatal growth in rural Zimbabwe.
por: Gough, Ethan K., et al.
Publicado: (2021)

Health Outcomes, Pathogenesis and Epidemiology of Severe Acute Malnutrition (HOPE-SAM): rationale and methods of a longitudinal observational study
por: Bwakura-Dangarembizi, Mutsa, et al.
Publicado: (2019)

Risk factors for inpatient mortality among children with severe acute malnutrition in Zimbabwe and Zambia
por: Sturgeon, Jonathan P., et al.
Publicado: (2023)

Environmental enteric dysfunction pathways and child stunting: A systematic review
por: Harper, Kaitlyn M., et al.
Publicado: (2018)

Recovery of children following hospitalisation for complicated severe acute malnutrition
por: Bwakura‐Dangarembizi, Mutsa, et al.
Publicado: (2021)

Proximal renal tubular function in HIV-infected children on tenofovir disoproxil fumarate for treatment of HIV infection at two tertiary hospitals in Harare, Zimbabwe
por: Mashingaidze-Mano, Runyararo, et al.
Publicado: (2020)

Postdischarge interventions for children hospitalized with severe acute malnutrition: a systematic review and meta-analysis
por: Noble, Christie C A, et al.
Publicado: (2021)

The impact of antibiotics on growth in children in low and middle income countries: systematic review and meta-analysis of randomised controlled trials
por: Gough, Ethan K, et al.
Publicado: (2014)

Successful treatment of cerebral toxoplasmosis with cotrimoxazole
por: Patil, Harsha V., et al.
Publicado: (2011)

Cotrimoxazole - optimal dosing in the critically ill
por: Brown, Glen R
Publicado: (2014)

Editorial Commentary: Genomic Epidemiology: Revealing Hidden Reservoirs for Klebsiella pneumoniae
por: Manges, Amee R.
Publicado: (2015)

Evaluation of weight‐based prescription of antiretroviral therapy in children
por: Dakshina, S, et al.
Publicado: (2019)

National policy development for cotrimoxazole prophylaxis in Malawi, Uganda and Zambia: the relationship between Context, Evidence and Links
por: Hutchinson, Eleanor, et al.
Publicado: (2011)

Comparison between Itraconazole and Cotrimoxazole in the Treatment of Paracoccidiodomycosis
por: Cavalcante, Ricardo de Souza, et al.
Publicado: (2014)

Cotrimoxazole: Stevens-Johnson syndrome: case report
Publicado: (2021)

Cotrimoxazole Prophylaxis and Tuberculosis Risk among People Living with HIV
por: Hoffmann, Christopher J., et al.
Publicado: (2014)

The fecal microbiome and rotavirus vaccine immunogenicity in rural Zimbabwean infants
por: Robertson, Ruairi C., et al.
Publicado: (2021)

Antimicrobial Use, Human Gut Microbiota and Clostridium difficile Colonization and Infection
por: Vincent, Caroline, et al.
Publicado: (2015)

Adult Hematology and Clinical Chemistry Laboratory Reference Ranges in a Zimbabwean Population
por: Samaneka, Wadzanai P., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ltdrjc31mko69hsgembo5mj7ed